Announcements Trials

Browse Landscape

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

pembrolizumab 375 Carboplatin 278 Specimen Handling 266 Nivolumab 253 Magnetic Resonance Spectroscopy 245 Cyclophosphamide 241 Cisplatin 214 Paclitaxel 206 Radiotherapy 196 Biopsy 171 Gemcitabine 156 Dexamethasone 148 durvalumab 143 atezolizumab 126 Rituximab 120 Doxorubicin 115 Bevacizumab 114 Lenalidomide 113 Ipilimumab 112 Radiation 110 Pemetrexed 103 Docetaxel 103 Etoposide 101 fludarabine 97 venetoclax 95 Fluorouracil 92 Capecitabine 92 Radiosurgery 90 Prednisone 89 Oxaliplatin 89

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Algorithms × 1 year × Clear all

NCT01806129 2026-06-03

EROS

Eastern Cooperative Oncology Group

Phase NA Active not recruiting

434 enrolled 9 charts

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡